Alkermes (ALKS) Short Interest Ratio & Short Volume → The biggest energy story ever? (From Porter & Company) (Ad) Free ALKS Stock Alerts $23.80 -0.74 (-3.02%) (As of 12:10 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Alkermes Short Interest DataCurrent Short Volume13,520,000 sharesPrevious Short Volume14,340,000 sharesChange Vs. Previous Month-5.72%Dollar Volume Sold Short$324.75 millionShort Interest Ratio / Days to Cover6.9Last Record DateApril 15, 2024Outstanding Shares169,180,000 sharesPercentage of Shares Shorted7.99%Today's Trading Volume1,139,947 sharesAverage Trading Volume1,878,500 sharesToday's Volume Vs. Average61% Short Selling Alkermes ? Sign up to receive the latest short interest report for Alkermes and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatALKS Short Interest Over TimeALKS Days to Cover Over TimeALKS Percentage of Float Shorted Over Time Ad Porter & CompanyTrump’s last act as President You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines. For the full story, click here. Alkermes Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202413,520,000 shares $324.75 million -5.7%N/A6.9 $24.02 3/31/202414,340,000 shares $388.18 million +1.9%N/A7.5 $27.07 3/15/202414,080,000 shares $404.80 million +8.1%N/A7.7 $28.75 2/29/202413,020,000 shares $386.56 million +6.6%N/A5.6 $29.69 2/15/202412,220,000 shares $397.88 million +4.8%N/A4.9 $32.56 1/31/202411,660,000 shares $315.40 million -11.9%N/A5 $27.05 Get the Latest News and Ratings for ALKS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alkermes and its competitors with MarketBeat's FREE daily newsletter. 1/15/202413,230,000 shares $373.09 million -5.6%N/A5 $28.20 12/31/202314,020,000 shares $388.91 million +44.8%N/A5.4 $27.74 12/15/20239,680,000 shares $265.43 million +24.4%N/A3.7 $27.42 11/30/20237,780,000 shares $187.81 million -2.3%N/A3.8 $24.14 11/15/20237,960,000 shares $188.73 million -0.4%N/A4.2 $23.71 10/31/20237,990,000 shares $193.28 million +9.9%N/A4.2 $24.19 10/15/20237,270,000 shares $201.60 million -16.8%N/A3.9 $27.73 9/30/20238,740,000 shares $244.81 million -10.0%N/A5.1 $28.01 9/15/20239,710,000 shares $287.42 million +2.4%N/A5.6 $29.60 8/31/20239,480,000 shares $276.72 million +16.0%N/A5.5 $29.19 8/15/20238,170,000 shares $235.79 million +33.7%N/A5.3 $28.86 7/31/20236,110,000 shares $178.90 million +1.0%N/A4.2 $29.28 7/15/20236,050,000 shares $184.16 million +3.6%N/A4.5 $30.44 6/30/20235,840,000 shares $182.79 million -8.9%N/A4.2 $31.30 6/15/20236,410,000 shares $204.67 million -10.1%N/A4.8 $31.93 5/31/20237,130,000 shares $206.27 million -4.4%N/A5.6 $28.93 5/15/20237,460,000 shares $231.26 million -1.8%N/A5.9 $31.00 4/30/20237,600,000 shares $216.98 million -13.9%N/A5.8 $28.55 4/15/20238,830,000 shares $259.16 million -5.3%N/A7.1 $29.35 3/31/20239,320,000 shares $262.73 million -1.6%N/A7.5 $28.19 3/15/20239,470,000 shares $252.09 million +5.5%N/A7.6 $26.62 2/28/20238,980,000 shares $240.13 million No ChangeN/A6.9 $26.74 2/15/20238,980,000 shares $242.37 million -1.8%N/A6.6 $26.99 1/31/20239,140,000 shares $261.77 million -2.4%N/A6.5 $28.64 1/15/20239,360,000 shares $255.62 million +1.9%N/A5.7 $27.31 12/30/20229,190,000 shares $240.13 million +3.6%N/A5.4 $26.13 12/15/20228,870,000 shares $222.55 million +1.4%N/A5.1 $25.09 11/30/20228,750,000 shares $216.83 million -4.0%N/A5.2 $24.78 11/15/20229,110,000 shares $205.70 million +2.7%N/A5.4 $22.58 10/31/20228,870,000 shares $201.35 million -2.4%N/A5.5 $22.70 10/15/20229,090,000 shares $205.62 million -0.8%N/A5.6 $22.62 9/30/20229,160,000 shares $204.54 million +4.9%N/A6.4 $22.33 9/15/20228,730,000 shares $207.51 million +5.1%N/A6.2 $23.77 8/31/20228,310,000 shares $196.70 million +8.2%N/A5.8 $23.67Have You Seen Elon’s New A.I. Device? (Picture Inside) (Ad)A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...This strange new device to protect us against that A.I. threat... ALKS Short Interest - Frequently Asked Questions What is Alkermes' current short interest? Short interest is the volume of Alkermes shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 13,520,000 shares of ALKS short. Learn More on Alkermes' current short interest. What is a good short interest ratio for Alkermes? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALKS shares currently have a short interest ratio of 7.0. Learn More on Alkermes's short interest ratio. Which institutional investors are shorting Alkermes? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Alkermes: Citadel Advisors LLC, Affinity Asset Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Alkermes' short interest increasing or decreasing? Alkermes saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 13,520,000 shares, a decline of 5.7% from the previous total of 14,340,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Alkermes' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Alkermes: Madrigal Pharmaceuticals, Inc. (17.14%), Amicus Therapeutics, Inc. (10.57%), Ionis Pharmaceuticals, Inc. (7.12%), Geron Co. (9.04%), Agios Pharmaceuticals, Inc. (12.15%), Dynavax Technologies Co. (14.17%), Ligand Pharmaceuticals Incorporated (4.98%), Pacira BioSciences, Inc. (7.42%), Ironwood Pharmaceuticals, Inc. (13.96%), MannKind Co. (13.21%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Alkermes stock? Short selling ALKS is an investing strategy that aims to generate trading profit from Alkermes as its price is falling. ALKS shares are trading down $0.34 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Alkermes? A short squeeze for Alkermes occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ALKS, which in turn drives the price of the stock up even further. How often is Alkermes' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALKS, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: MDGL Short Interest Data FOLD Short Interest Data IONS Short Interest Data GERN Short Interest Data AGIO Short Interest Data DVAX Short Interest Data LGND Short Interest Data PCRX Short Interest Data IRWD Short Interest Data MNKD Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ALKS) was last updated on 5/1/2024 by MarketBeat.com Staff From Our PartnersAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Report#1 election stockPorter & Company😱 This phenomenon is smashing regular market gainsMillPubDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing4 coins to be the “Next Bitcoin”True Market Insiders